Celgene signs $177 million OncoMed deal
December 4, 2013Research and Development, Sales and Marketing Cancer, Celgene, OncoMed, stem cell
Celgene Corporation is paying OncoMed Pharmaceuticals $177.25 million to get access to its pipeline as part of a deal to …
Report: ‘R&D isn’t paying’
December 3, 2013Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters
On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …
£10 million competition for gene mapping
December 3, 2013Research and Development, Sales and Marketing DNA, UK, cansar, genes, mapping
The Department of Health has launched a £10 million competition to fund businesses working on new technology which will map …
Witty goes to China
December 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery
GlaxoSmithKline chief executive Sir Andrew Witty has embarked on a potentially delicate diplomatic mission as part of a UK trade …
Aptuit hires chief executive from ICON
December 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aptuit, ICON, goldman
Drug development services firm Aptuit has named Dr Jonathan Goldman as its chief executive, completing the company’s senior management leadership …
EU GMP revision comments focus on cross-contamination
December 3, 2013Manufacturing and Production Contamination, EFPIA, EU, GMP
Earlier this year the EU Commission published draft versions of four chapters in its Good Manufacturing Practice (GMP) guide, and …
Pharmafocus in the palm of your hand
December 2, 2013Medical Communications Pharmafocus, Samedan, app, pharmafile
From Thursday 5 December you will be able to access the digital edition of Pharmafocus on your Apple device via …
Eisai reorganises R&D
December 2, 2013Research and Development, Sales and Marketing Eisai, R&D, cfu, epcs, pcu, reorganisation
Tokyo-based Eisai is to axe 130 jobs in Europe and the US as part of an attempt to shake up …
Merck to close Irish plant with loss of 570 jobs
December 2, 2013Manufacturing and Production, Sales and Marketing Ireland, MSD, Merck, job cuts, swords
Merck & Co has said it plans to close down a facility in Ireland with the loss of around 570 …
DH publishes dementia map
December 2, 2013Research and Development, Sales and Marketing Department of Health, Hunt, dementia
People will be able to view the quality of dementia care and support in their local area, thanks to a …
GSK veteran named chief executive for Takeda
December 2, 2013Sales and Marketing GSK, Takeda, christophe weber
Asia’s biggest drugmaker Takeda has named GlaxoSmithKline’s Christophe Weber as the leading candidate for the role of its next chief …
EU rethinks regulation
December 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Goldacre, Les Rose, MHRA, regulation
What has happened to the science in clinical research? Well, it is still there, but with the explosion in the …
MHP announces string of new hires
December 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mhp, naish
MHP Communications has announced the appointment of a number of senior and mid-level hires to increase its health practice. Paul …
FDA slaps import ban on Wockhardt facility
November 29, 2013Manufacturing and Production FDA, MHRA, Wockhardt, recall
The US Food and Drug Administration has banned imports of medicines made at Wockhardt’s Chikalthana plant in India that failed …
BTG gets FDA nod
November 29, 2013Sales and Marketing BTG, FDA, Varithena, varicose vein
UK healthcare group BTG has received approval from the FDA for a new type of varicose vein treatment to be …
GSK using ‘sledgehammer’ tactics on agencies
November 29, 2013Sales and Marketing Cameron, China, GSK, horlicks, sky
GlaxoSmithKline is being accused of using ‘sledgehammer’ tactics by marketing agencies promoting its products after the firm allegedly demanded cash …
ICON hires Manuel Ploch to head-up Japan


November 29, 2013Contract research organisation ICON has appointed Manuel Ploch to be its general manager in Japan. Ploch will lead all of …
‘TripAdvisor’ site for NHS
November 29, 2013Medical Communications, Sales and Marketing NHS, NHS Choices, TripAdvisor
EMA speeds up Boehringer review
November 28, 2013Sales and Marketing Boehringer, faldaprevir, hepc
Boehringer Ingelheim’s hepatitis C candidate faldaprevir has moved a potential step closer to market with the news that the European …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
